Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Votes Millions More For NIH Precision Medicine, BRAIN Initiatives

This article was originally published in The Gray Sheet

Executive Summary

The Senate Appropriations Committee approved an appropriations bill for 2017 that would increase funding for the Precision Medicine Initiative and the BRAIN Initiative at the National Institutes of Health, and eliminate funding for the Independent Payment Advisory Board. Overall, NIH would see a $2bn increase over 2016 funding levels.

You may also be interested in...



White House Grants $86M To Propel BRAIN, Precision Medicine Initiatives

The Obama administration announced a total of $86m in new grant funds to propel the National Institute of Health’s BRAIN Initiative and Precision Medicine Initiative forward, among other innovative science research programs.

NIH Highlights Advanced Imaging, Neurostim Technologies In Funding Appeal

Further development of medical technologies to advance brain disease diagnoses, treat spinal cord injuries and manage pain without the use of addictive opioids would be key beneficiaries if additional funding from Congress for the National Institutes of Health comes through, NIH head Francis Collins told appropriators.

HHS Appointee Burwell Tells Senate Panel IPAB Will ‘Never Be Activated’

HHS Secretary nominee Sylvia Mathews Burwell told Senate HELP Committee members at her May 8 nomination hearing that the Independent Payment Advisory Board required by the Affordable Care Act will likely “never be activated” because the Obama administration has been able to lower health care costs.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT034852

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel